Use of topoisomerase II alpha (TOP2A) protein overexpression to predict response to anthracycline-based chemotherapy.
S. Chan
No relevant relationships to disclose
J. S. Reis-Filho
No relevant relationships to disclose
P. D. Dickinson
No relevant relationships to disclose
P. Moseley
No relevant relationships to disclose
A. R. Green
No relevant relationships to disclose
I. O. Ellis
No relevant relationships to disclose
T. M. A. Abdel-Fatah
No relevant relationships to disclose